290 related articles for article (PubMed ID: 10069683)
1. Cardiac effects of beta-adrenoceptor antagonists with intrinsic sympathomimetic activity in humans: beta1- and/or beta2-adrenoceptor mediated?
Jakubetz J; Schmuck S; Poller U; Fuchs B; Gorf A; Radke J; Pönicke K; Brodde OE
J Cardiovasc Pharmacol; 1999 Mar; 33(3):461-72. PubMed ID: 10069683
[TBL] [Abstract][Full Text] [Related]
2. Terbutaline-induced desensitization of human cardiac beta 2-adrenoceptor-mediated positive inotropic effects: attenuation by ketotifen.
Poller U; Fuchs B; Gorf A; Jakubetz J; Radke J; Pönicke K; Brodde OE
Cardiovasc Res; 1998 Oct; 40(1):211-22. PubMed ID: 9876334
[TBL] [Abstract][Full Text] [Related]
3. Celiprolol: agonist and antagonist effects at cardiac beta 1- and vascular beta 2-adrenoceptors determined under in vivo conditions in the rat.
Alvarez-Guerra M; Alda O; Garay RP
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):689-98. PubMed ID: 9205952
[TBL] [Abstract][Full Text] [Related]
4. Heart-rate variability effects of beta-adrenoceptor agonists (xamoterol, prenalterol, and salbutamol) assessed nonlinearly with scatterplots and sequence methods.
Silke B; Hanratty CG; Riddell JG
J Cardiovasc Pharmacol; 1999 Jun; 33(6):859-67. PubMed ID: 10367588
[TBL] [Abstract][Full Text] [Related]
5. Human cardiac beta1- or beta2-adrenergic receptor stimulation and the negative chronotropic effect of low-dose pirenzepine.
Jakubetz J; Schmuck S; Wochatz G; Ruhland B; Poller U; Radke J; Brodde OE
Clin Pharmacol Ther; 2000 May; 67(5):549-57. PubMed ID: 10824634
[TBL] [Abstract][Full Text] [Related]
6. Effects of atropine on human cardiac beta 1- and/or beta 2-adrenoceptor stimulation.
Bruck H; Ulrich A; Gerlach S; Radke J; Brodde OE
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):572-7. PubMed ID: 12759717
[TBL] [Abstract][Full Text] [Related]
7. Beta 2-adrenoceptor-mediated intrinsic sympathomimetic activity of carteolol: an in vivo study.
Bruck H; Poller U; Lüssenhop H; Pönicke K; Temme T; Heusch G; Philipp T; Brodde OE
Naunyn Schmiedebergs Arch Pharmacol; 2004 Nov; 370(5):361-8. PubMed ID: 15526107
[TBL] [Abstract][Full Text] [Related]
8. Ketotifen and cardiovascular effects of xamoterol following single and chronic dosing in healthy volunteers.
Schäfers RF; Karl I; Mennicke K; Daul AE; Philipp T; Brodde OE
Br J Clin Pharmacol; 1999 Jan; 47(1):59-66. PubMed ID: 10073741
[TBL] [Abstract][Full Text] [Related]
9. Effects of beta-adrenoceptor agonists and antagonists on heart-rate variability in normal subjects assessed using summary statistics and nonlinear procedures.
Silke B; Guy S; Riddell JG
J Cardiovasc Pharmacol; 1997 Dec; 30(6):817-23. PubMed ID: 9436823
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo characterization of intrinsic sympathomimetic activity in normal and heart failure rats.
Willette RN; Aiyar N; Yue TL; Mitchell MP; Disa J; Storer BL; Naselsky DP; Stadel JM; Ohlstein EH; Ruffolo RR
J Pharmacol Exp Ther; 1999 Apr; 289(1):48-53. PubMed ID: 10086986
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the beta1-selectivity of three beta1-selective beta-blockers.
Nuttall SL; Routledge HC; Kendall MJ
J Clin Pharm Ther; 2003 Jun; 28(3):179-86. PubMed ID: 12795776
[TBL] [Abstract][Full Text] [Related]
12. Disodium cromoglycate does not prevent terbutaline-induced desensitization of beta 2-adrenoceptor-mediated cardiovascular in vivo functions in human volunteers.
Schäfers RF; Piest U; von Birgelen C; Jakubetz J; Daul AE; Philipp T; Brodde OE
J Cardiovasc Pharmacol; 1999 May; 33(5):822-7. PubMed ID: 10226872
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
14. Positive inotropic effects of the beta 2-adrenoceptor agonist terbutaline in the human heart: effects of long-term beta 1-adrenoceptor antagonist treatment.
Schäfers RF; Adler S; Daul A; Zeitler G; Vogelsang M; Zerkowski HR; Brodde OE
J Am Coll Cardiol; 1994 Apr; 23(5):1224-33. PubMed ID: 8144793
[TBL] [Abstract][Full Text] [Related]
15. Differential changes in lymphocyte beta 2-adrenoceptor density by beta-blocker administration: role of intrinsic sympathomimetic activity.
Daul A; Wang XL; Borchard U; Bock KD; Brodde OE
J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S93-6. PubMed ID: 2427860
[TBL] [Abstract][Full Text] [Related]
16. Beta-adrenoceptor antagonists (non-selective as well as beta 1-selective) with partial agonistic activity decrease beta 2-adrenoceptor density in human lymphocytes. Evidence for a beta 2-agonistic component of the partial agonistic activity.
Brodde OE; Schemuth R; Brinkmann M; Wang XL; Daul A; Borchard U
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jun; 333(2):130-8. PubMed ID: 2875397
[TBL] [Abstract][Full Text] [Related]
17. Functional beta1- and beta2-adrenoceptors in the left and right atrium of pre-hypertensive rats.
Doggrell SA
J Pharm Pharmacol; 2002 Oct; 54(10):1407-12. PubMed ID: 12396304
[TBL] [Abstract][Full Text] [Related]
18. Influence of adrenoceptor and muscarinic receptor blockade on the cardiovascular effects of exogenous noradrenaline and of endogenous noradrenaline released by infused tyramine.
Schäfers RF; Poller U; Pönicke K; Geissler M; Daul AE; Michel MC; Brodde OE
Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):239-49. PubMed ID: 9050018
[TBL] [Abstract][Full Text] [Related]
19. Heart rate variability effects of an agonist or antagonists of the beta-adrenoceptor assessed with scatterplot and sequence analysis.
Silke B; Riddell JG
Clin Auton Res; 1998 Jun; 8(3):145-53. PubMed ID: 9651664
[TBL] [Abstract][Full Text] [Related]
20. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
